Open AccessINVESTIGATIONAL CANCER DRUG INHIBITS THE EXTRACELLULAR SIGNAL REGULATED PROTEIN KINASES (ERK1): AN IN-SILICO APPROACH
Author(s) -
S. Hemalatha,
Kiresee Saghana P R,
Anand Krishnamurthy
Publication year - 2015
Publication title -
international journal of research in ayurveda and pharmacy
Language(s) - English
Resource type - Journals
eISSN - 2277-4343
pISSN - 2229-3566
DOI - 10.7897/2277-4343.06128
Subject(s) - in silico , extracellular signal regulated kinases , kinase , extracellular , drug , cancer , drug discovery , drug development , cancer research , pharmacology , phosphorylation , microbiology and biotechnology , chemistry , computational biology , medicine , biology , protein kinase a , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom